StockTipsArenaBeta

BUY Jubilant Ingrevia Limited — Narendra Solanki, Anand Rathi

BUYJubilant Ingrevia Limited
Jubilant Ingrevia share price target & all analyst calls

byNarendra Solanki, Anand RathiHorizon: NA (inferred 1 year)28 Jul 2026via CNBC Awaaz.

Entry₹736.45Inferred
Target₹980
Total upside +33.07%
Stop lossNot given
CMP₹558.45h ago
Active-24.18%+75.50%upside left 9 mo left
Follow Narendra Solanki for new callsGet alertsWatch JUBLINGREA for new buy/sell callsGet alertsSee 7 other Long-term calls on JUBLINGREASee 411 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 30 Oct, 9:24 pm IST
15 supporting7 neutral2 opposing
Supports the BUY call (15)

3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·28 Oct · 2d ago

Jubilant Ingrevia Q2 results: Stock gains as much as 8% after Nutrition & Health Solutions aid earnings growth

NewsCnbc-Tv18·27 Oct · 3d ago

(opens in new tab)

Jubilant Ingrevia reported strong Q2 FY27 financial results with revenue up 24% YoY to Rs 1,394 crore and EBITDA up 51% YoY to Rs 221 crore. The company also announced a 40% stake acquisition in Zetta

NSE · Press Release·27 Oct · 3d ago

(opens in new tab)

Jubilant Ingrevia reported standalone net profit of 70.40 crore for the quarter ended September 30, 2026, compared to 44.03 crore in the same quarter last year. The company also announced a 40% stake

NSE · Outcome of Board Meeting·27 Oct · 3d ago

(opens in new tab)
Neutral / worth noting (7)

The company incorporated a new wholly owned subsidiary.

BSE · Company Update·1 Oct · 4w ago

(opens in new tab)

The company board approved the incorporation of a wholly owned subsidiary.

NSE · Outcome of Board Meeting·1 Oct · 4w ago

(opens in new tab)
Weighs against the BUY call (2)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·30 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Jubilant Ingrevia

All analyst calls on Jubilant Ingrevia

More from Narendra Solanki, Anand Rathi

Every call and its outcome